Five Prime Stock Price, News & Analysis

FPRX NASDAQ

Company Description

Five Prime (NASDAQ: FPRX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

FPRX stock has gained 1252.3% over the past year.

This page provides a comprehensive overview of FPRX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+1252.31%

Performance 1 year

$0.0

Market Cap

46.6M

Shares outstanding

Five Prime (FPRX) stock. Over the past 12 months, the stock has gained 1252.3%.

Latest News

View All

April 16, 2021

—

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

acquisition

March 9, 2021

-0.92%

Five Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference Call

conferences earnings

March 4, 2021

+78.74%

Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash

acquisition

March 4, 2021

+78.74%

Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash

acquisition

March 2, 2021

-4.71%

Five Prime Therapeutics Announces Timing of Its Fourth Quarter 2020 and Full Year Results Conference Call

conferences earnings

February 26, 2021

+5.40%

Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference

conferences

Five Prime has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, conferences, earnings, clinical trial. View all FPRX news →

SEC Filings

View All

No SEC filings available for FPRX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

FPRX Company Profile & Sector Positioning

Five Prime (FPRX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.